M.A. Muros

Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels

M.A. Muros, J.M. Llamas Elvira, Á. Ramírez-Navarro et al. · The American Journal of Surgery · 2000 · 80 citations

Positron Emission Tomography, Serum Thyroglobulin Levels, Thyroid Disease +7

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study

Mercedes Mitjavila, Paula Jiménez‐Fonseca, Pilar Belló et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 52 citations · Full text

Clinical and Pathological Factors Related to 18F-FDG-PET Positivity in the Diagnosis of Recurrence and/or Metastasis in Patients with Differentiated Thyroid Cancer

David Esteva, M.A. Muros, J.M. Llamas Elvira et al. · Annals of Surgical Oncology · 2009 · 30 citations

Medicine, Thyroid Disease, Pathology +7

The role of somatostatin receptor scintigraphy in patients with pituitary adenoma or post-surgical recurrent tumours

M J Acosta-Gómez, M.A. Muros, J.M. Llamas Elvira et al. · British Journal of Radiology · 2005 · 23 citations

Surgical Oncology, Pathology, Confirmed Pituitary Tumours +16

Two-phase scintigraphy with technetium 99m–sestamibi in patients with hyperparathyroidism due to chronic renal failure

M.A. Muros, Juan Bravo Soto, José M. López Ruiz et al. · The American Journal of Surgery · 2007 · 20 citations

Technetium 99M–sestamibi, Urology, Chronic Renal Failure +9